Shyr Y - Search Results

1

RAF265 inhibits the growth of advanced human melanoma tumors.

Su Y, Vilgelm AE, Kelley MC, Hawkins OE, Liu Y, Boyd KL, Kantrow S, Splittgerber RC, Short SP, Sobolik T, Zaja-Milatovic S, Dahlman KB, Amiri KI, Jiang A, Lu P, Shyr Y, Stuart DD, Levy S, Sosman JA, Richmond A. Su Y, et al. Among authors: shyr y. Clin Cancer Res. 2012 Apr 15;18(8):2184-98. doi: 10.1158/1078-0432.CCR-11-1122. Epub 2012 Feb 20. Clin Cancer Res. 2012. PMID: 22351689 Free PMC article.

2

Antioxidants reduce cyclooxygenase-2 expression, prostaglandin production, and proliferation in colorectal cancer cells.

Chinery R, Beauchamp RD, Shyr Y, Kirkland SC, Coffey RJ, Morrow JD. Chinery R, et al. Among authors: shyr y. Cancer Res. 1998 Jun 1;58(11):2323-7. Cancer Res. 1998. PMID: 9622066

3

Treatment with farnesyl-protein transferase inhibitor induces regression of mammary tumors in transforming growth factor (TGF) alpha and TGF alpha/neu transgenic mice by inhibition of mitogenic activity and induction of apoptosis.

Nørgaard P, Law B, Joseph H, Page DL, Shyr Y, Mays D, Pietenpol JA, Kohl NE, Oliff A, Coffey RJ Jr, Poulsen HS, Moses HL. Nørgaard P, et al. Among authors: shyr y. Clin Cancer Res. 1999 Jan;5(1):35-42. Clin Cancer Res. 1999. PMID: 9918200

4

Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: a multicenter phase II study.

Jagasia MH, Langer CJ, Johnson DH, Yunus F, Rodgers JS, Schlabach LL, Cohen AG, Shyr Y, Carbone DP, Devore RF. Jagasia MH, et al. Among authors: shyr y. Clin Cancer Res. 2001 Jan;7(1):68-73. Clin Cancer Res. 2001. PMID: 11205920 Clinical Trial.

5

Hepatocellular carcinoma results from chronic cyclin D1 overexpression in transgenic mice.

Deane NG, Parker MA, Aramandla R, Diehl L, Lee WJ, Washington MK, Nanney LB, Shyr Y, Beauchamp RD. Deane NG, et al. Among authors: shyr y. Cancer Res. 2001 Jul 15;61(14):5389-95. Cancer Res. 2001. PMID: 11454681

6

A pilot study of neoadjuvant paclitaxel and radiation with correlative molecular studies in stage II/III breast cancer.

Chakravarthy A, Nicholson B, Kelley M, Beauchamp D, Johnson D, Frexes-Steed M, Simpson J, Shyr Y, Pietenpol J. Chakravarthy A, et al. Among authors: shyr y. Clin Breast Cancer. 2000 Apr;1(1):68-71. doi: 10.3816/CBC.2000.n.007. Clin Breast Cancer. 2000. PMID: 11899393

7

A training-testing approach to the molecular classification of resected non-small cell lung cancer.

Yamagata N, Shyr Y, Yanagisawa K, Edgerton M, Dang TP, Gonzalez A, Nadaf S, Larsen P, Roberts JR, Nesbitt JC, Jensen R, Levy S, Moore JH, Minna JD, Carbone DP. Yamagata N, et al. Among authors: shyr y. Clin Cancer Res. 2003 Oct 15;9(13):4695-704. Clin Cancer Res. 2003. PMID: 14581339

8

Significance of p63 amplification and overexpression in lung cancer development and prognosis.

Massion PP, Taflan PM, Jamshedur Rahman SM, Yildiz P, Shyr Y, Edgerton ME, Westfall MD, Roberts JR, Pietenpol JA, Carbone DP, Gonzalez AL. Massion PP, et al. Among authors: shyr y. Cancer Res. 2003 Nov 1;63(21):7113-21. Cancer Res. 2003. PMID: 14612504

9

Gene expression profile analysis of mouse colon embryonic development.

Park YK, Franklin JL, Settle SH, Levy SE, Chung E, Jeyakumar LH, Shyr Y, Washington MK, Whitehead RH, Aronow BJ, Coffey RJ. Park YK, et al. Among authors: shyr y. Genesis. 2005 Jan;41(1):1-12. doi: 10.1002/gene.20088. Genesis. 2005. PMID: 15645444

10

Targeting cyclooxygenase-2 in recurrent non-small cell lung cancer: a phase II trial of celecoxib and docetaxel.

Csiki I, Morrow JD, Sandler A, Shyr Y, Oates J, Williams MK, Dang T, Carbone DP, Johnson DH. Csiki I, et al. Among authors: shyr y. Clin Cancer Res. 2005 Sep 15;11(18):6634-40. doi: 10.1158/1078-0432.CCR-05-0436. Clin Cancer Res. 2005. PMID: 16166442 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

717 results

Search Page